Pfizer Headquarters Office-to-Residential Conversion

Deal value: $720,000,000

Conversion of Pfizer’s former Midtown Manhattan headquarters into a 1,602-unit multifamily mixed-use property, including retail and amenity spaces.

The core motivation is to capitalize on the structural shift in Manhattan’s real estate market, where declining office demand—exacerbated by remote work—has created opportunities to address the city’s acute housing shortage. The strategic purpose is to transform underutilized office assets into high-demand multifamily housing, leveraging city tax incentives for affordable units and responding to policy and market calls for more residential supply in Midtown. The belief driving this allocation is that prime-location conversions can deliver attractive, risk-adjusted returns while meeting urgent social needs.